Pentraxin 3: A Novel Biomarker for Inflammatory Cardiovascular Disease
Numerous studies have recently examined the role of pentraxin 3 (PTX3) in clinical situations. The pentraxin family includes C-reactive protein (CRP); however, unlike CRP, PTX3 is expressed predominantly in atherosclerotic lesions that involve macrophages, neutrophils, dendritic cells, or smooth mus...
Saved in:
| Main Authors: | Kenji Inoue, Tatsuhiko Kodama, Hiroyuki Daida |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | International Journal of Vascular Medicine |
| Online Access: | http://dx.doi.org/10.1155/2012/657025 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of the inflammatory protein Pentraxin 3 as a biomarker in patients with ischemic heart disease
by: D. Hristov
Published: (2024-12-01) -
Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases
by: Fabrizia Bonacina, et al.
Published: (2013-01-01) -
Pentraxin 3: a novel biomarker in pediatric central nervous system infections
by: Huda El-Kady, et al.
Published: (2025-01-01) -
Pentraxin 3(PTX 3): An Endogenous Modulator of the Inflammatory Response
by: P. Kunes, et al.
Published: (2012-01-01) -
Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or Infection
by: Siguan Liu, et al.
Published: (2014-01-01)